Research teams, sponsors and CROs comparing data collection for clinical trials, from focused participant-centered studies to complex multi-site protocols.
Scope Dedicated EDC systems and participant-centered clinical-trial data collection are compared by their documented capabilities. Whether a participant-centered platform also needs a dedicated EDC depends on in-visit data entry, clinical queries, coding, verification and database-management requirements, rather than study size or trial phase alone.
These notes describe the products in the EDC guide.
OpenClinica
Best for
Academic groups, CROs and small sponsors that want published per-study prices and standards-based data exchange.
What to consider
OpenClinica is the only commercial EDC here with public list prices, and it documents an ODM-based REST API. It has fewer native modules than the enterprise suites, and Everest Group rated it a Major Contender, not a Leader, in 2024.
Sponsors and CROs already on Veeva's clinical platform who want EDC, RTSM, eCOA and CTMS from the same vendor.
What to consider
Veeva EDC documents mid-study changes and connected clinical applications, and Veeva says eight of the top 20 biopharmas have switched to it. Veeva publishes no study count and no prices.
Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.
Expand a feature definition or support note for context and its original source.
OpenClinica vs Veeva EDC (EDC): category feature evidence and sources. Products are not ranked.
Category feature
OpenClinica
Veeva EDC
Track record in regulated multi-site trialsFeature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
OpenClinica
Supported
OpenClinica says its technology has powered over 15,000 studies and more than three million patients.
Self-build and managed build are stated; amendment deployment is not documented.
Veeva EDC
Supported
Veeva's white paper states that amendments add new elements without bringing the system down or migrating data, with only a brief casebook lockout while a change deploys.
Trial standards and ISO/SOC claims are stated; public certificate or report access is not established.
Veeva EDC
Supported
Veeva's trust page lists ISO 27001, ISO 27017, ISO 27018 and a SOC 2 Type II report, and its EDC help docs state that Veeva EDC eSignature meets 21 CFR Part 11.
The REST API imports and retrieves clinical data in CDISC ODM.
Veeva EDC
Supported
Veeva documents a versioned CDMS API for study data, definitions and coding requests with a data model similar to CDISC ODM, but its ODM casebook export is a legacy feature.